Reviewed by Julian Douwes M.D., Chief Medical Officer, Klinik St. Georg
Chronic Lyme disease is a systemic illness. It affects the immune system, the nervous system, the cardiovascular system, and the musculoskeletal system simultaneously. Treating it with a single therapy is like trying to rebuild a house by replacing only one wall. The approach must be as comprehensive as the disease itself.
What it is: A coordinated, multimodal treatment program that combines whole-body hyperthermia, targeted antimicrobials, immune modulation, H.E.L.P. apheresis, IV laser therapy, and detoxification support into one individualized protocol.
Why it matters: Single-therapy approaches frequently fail for chronic Lyme because Borrelia exists in multiple forms, in multiple body compartments, protected by biofilms and immune evasion mechanisms. Addressing only one aspect leaves others untouched.
Who coordinates it: A dedicated medical team works together at one facility, adjusting the protocol in real time based on your response, laboratory findings, and clinical progress.
If you have been living with chronic Lyme disease, you have probably tried more than one approach. Perhaps a course of oral antibiotics, then intravenous antibiotics, then herbal protocols, then something else. And perhaps each one helped a little, or for a while, but never resolved the full picture.
There are well-documented reasons why this happens:
Borrelia exists in multiple forms. The Lyme spirochete does not remain in one shape. It transitions between active spirochetal forms, dormant round bodies (cysts), and protective biofilm communities. A therapy that targets one form may leave the others largely unaffected. When treatment stops, the surviving forms can reactivate.
The immune system becomes dysregulated. Chronic Borrelia infection does not simply persist because the bacteria are hard to kill. It persists in part because the immune response itself becomes dysfunctional. Chronic inflammation, autoimmune-like reactions, and immune exhaustion create a self-sustaining cycle even when bacterial load is reduced.
Tissue compartments limit drug penetration. Borrelia is known to cross the blood-brain barrier, colonize collagen-rich tissues such as joints and tendons, and persist in intracellular niches. Oral and even intravenous antibiotics may not achieve therapeutic concentrations in every compartment where the organism resides.
Toxic burden compounds the problem. Years of chronic infection, repeated antibiotic courses, inflammatory byproducts, and immune complex accumulation create a significant toxic and inflammatory burden. Killing bacteria without supporting the body's ability to clear the resulting debris can lead to symptom flares rather than improvement.
These realities are not hypothetical. They are what we observe in patient after patient who arrives having already tried individual therapies. The logic of integrative treatment follows directly from the biology of the disease.
Our integrative treatment program is not a menu of optional add-ons. It is a structured clinical protocol in which each component serves a specific purpose and is timed to work synergistically with the others. The medical team at Klinik St. Georg coordinates every element based on your individual diagnostic findings, medical history, and treatment response.
Whole-body hyperthermia is the cornerstone of the protocol. Your core temperature is raised to 41.6–41.8°C under sedation, maintained for a controlled period, then carefully brought back down. At these temperatures, Borrelia spirochetes become structurally unstable. The heat also enhances immune function, increases tissue perfusion, and improves the penetration and efficacy of concurrent antimicrobial agents.
This is not experimental. Klinik St. Georg has performed over 30,000 hyperthermia sessions using the Heckel HT3000 medical device. Each session takes place in a hospital inpatient setting with continuous cardiopulmonary monitoring.
Learn more about hyperthermia for Lyme disease
Antimicrobials are administered strategically, not as a standalone treatment but timed to coincide with hyperthermia sessions. This approach, sometimes called antibiotic-augmented thermotherapy, takes advantage of the fact that elevated core temperature increases blood flow, tissue permeability, and bacterial metabolic activity, all of which can enhance antimicrobial efficacy.
The specific agents are selected based on your diagnostic workup, including testing for co-infections such as Babesia, Bartonella, Anaplasma, and Ehrlichia. The protocol may include antibiotics, antifungals, or antiparasitic agents as indicated. The goal is precision: the right agents, at the right time, in combination with the modalities that give them the best chance of reaching their targets.
Read our balanced assessment of antibiotic treatment for Lyme
Chronic Lyme disease is as much an immune disorder as it is an infectious one. Years of active infection dysregulate the immune system in measurable ways: elevated inflammatory cytokines, suppressed natural killer cell activity, and disrupted T-cell and B-cell function.
The immune modulation component of the protocol addresses this directly. Depending on your laboratory findings, interventions may include:
These are not alternative medicine additions. They are evidence-informed interventions selected based on measurable immune parameters in your bloodwork.
H.E.L.P. (Heparin-induced Extracorporeal LDL Precipitation) apheresis is a blood filtration procedure that removes inflammatory mediators, immune complexes, fibrinogen, and other circulating factors that perpetuate the chronic inflammatory state.
For patients with significant immune complex deposition, high inflammatory markers, or cardiovascular involvement, apheresis can produce rapid improvements in symptoms such as brain fog, fatigue, and circulatory complaints. It also reduces the overall inflammatory burden, making other therapies more effective.
Learn about apheresis for Lyme disease
Intravenous laser therapy delivers specific wavelengths of light directly into the bloodstream via a fiber optic catheter. Different wavelengths have different biological effects: red light (635nm) enhances mitochondrial function and tissue repair, blue light (405nm) has antimicrobial properties, green light (532nm) supports detoxification, and yellow light (589nm) has anti-inflammatory effects.
IV laser is typically administered in a rotating protocol across the treatment program, selected based on the treatment phase and your clinical needs. The therapy supports cellular energy production, microcirculation, and immune function at a systemic level.
When Borrelia organisms die, whether from hyperthermia, antimicrobials, or immune clearance, they release endotoxins and inflammatory fragments. This process, sometimes called a Herxheimer-like reaction, can temporarily worsen symptoms if the body's detoxification pathways are overwhelmed.
The detoxification component of the protocol is designed to support clearance of these byproducts and minimize treatment-related symptom flares. Specific measures may include:
Detoxification is not an afterthought. It is scheduled proactively throughout the treatment timeline, intensifying around hyperthermia sessions when bacterial die-off is expected to be greatest.
One of the most important differences between an integrative program and a collection of individual treatments is coordination. At Klinik St. Georg, your program is managed by a dedicated medical team that meets regularly to review your progress and adjust the protocol.
Before treatment begins, you undergo a comprehensive diagnostic workup that includes advanced Borrelia-specific testing, co-infection panels, immune function markers, inflammatory markers, and organ function assessments. These results form the foundation of your individualized plan.
During treatment, your physicians, nursing staff, and therapeutic team communicate daily. If a hyperthermia session produces a strong reaction, the antimicrobial timing may be adjusted. If laboratory values shift, immune support is modified. If you experience unexpected symptoms, the team responds within hours, not days.
After treatment, you receive a detailed protocol for the post-discharge period, including follow-up laboratory schedules, supplementation plans, and communication channels for ongoing questions. We also coordinate directly with your physicians at home when requested.
This level of coordination is possible because all components of the program take place at one facility, under one clinical team, over a 2–3 week inpatient stay. You are not managing a patchwork of providers. Your team is managing everything together.
Integrative Lyme treatment is most commonly appropriate for patients who:
The program is not appropriate for everyone, and not every patient responds equally. During the consultation process, our physicians assess your history, laboratory findings, and overall health to determine whether this approach is a reasonable option for your situation. If it is not, we will tell you that honestly.
The cornerstone of the protocol. Learn how controlled therapeutic fever targets Borrelia at temperatures where it becomes structurally unstable.
Blood filtration that removes inflammatory mediators and immune complexes, reducing the chronic inflammatory burden that perpetuates symptoms.
A balanced look at antibiotics as first-line treatment for acute Lyme and their role within integrative protocols for chronic disease.
Every case is different. A consultation with our medical team is the first step to understanding whether a multimodal approach is appropriate for your situation.
Request a case review